Hello followers! Today, we dive into the exciting world of Hinge Health, a company setting its sights on going public.

Established for 10 years, Hinge Health offers innovative digital solutions targeting chronic musculoskeletal issues. They’ve filed to go public and are eyeing to raise an impressive $500 million in their IPO.

In their quest to raise funds, Hinge has not yet detailed the share pricing, but estimates suggest a potential substantial funding round as calculated by IPO specialists at Renaissance Capital.

Last year, Hinge Health reported revenue of $390 million, reflecting a significant 33% growth from the previous year. Moreover, their net losses have decreased remarkably, now at $11.9 million compared to a hefty $108 million in 2023.

Utilizing advanced wearable sensors teamed with computer vision technology, Hinge’s innovative approach aims to alleviate musculoskeletal pain through remote monitoring by a skilled team of physical therapists and health coaches.

In late 2021, Hinge Health was valued at $6.2 billion after securing $400 million in funding from Tiger Global and Coatue Management, tallying their total funding to $828 million.

The company’s biggest investors include Insight Partners and Atomico, owning 19% and 15% of shares, respectively, along with a host of others holding approximately 8% shares each.

Hinge competes with companies such as Sword Health, which recently achieved a valuation of $3 billion, alongside others like Kaia Health Software and Omada Health.